Key result
Reperfusion therapy is linked to improved clinical outcomes in elderly STEMI patients.
Why the study?
The optimal management and efficacy and safety of reperfusion therapy for STEMI in patients over 75 years old require further prospective study.
Does reperfusion therapy improve outcomes in patients older than 75 years with STEMI?
Does reperfusion therapy improve outcomes in patients older than 75 years with STEMI?
Reperfusion therapy has a positive impact on outcomes in STEMI patients older than 75 years, though prospective studies are needed to determine optimal management in this demographic.
Answers are grounded in this paper and cite their sources.
Supports reperfusion in elderly STEMI from registry data; leaves open optimal strategies pending prospective trials.
The review analyzes studies on the efficacy and safety of reperfusion therapy for ST-segment elevation myocardial infarction in patients over 75 years of age. Registers data on the positive impact of reperfusion treatments on outcomes in older patients hospitalized with STEMI are given. Particular emphasis is put on the need for prospective studies to determine the optimal tactics for managing older and oldest older patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Duplyakova et al. (2023) conducted a review in ST-segment elevation myocardial infarction. Reperfusion therapy was evaluated on Efficacy and safety outcomes. Reperfusion therapy demonstrated a positive impact on outcomes in patients over 75 years of age hospitalized with STEMI based on registry data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: